Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Raspberry Pi Foundation agrees to sell 10.9 million shares

(Sharecast News) - Raspberry Pi announced on Thursday that the Raspberry Pi Foundation had agreed to sell 10.9 million existing shares at 550p each, raising gross proceeds of about £60m through a placing to strategic and institutional investors and a separate retail offer. The FTSE 250 microcomputing giant said the sale shares represented around 5.6% of Raspberry Pi's issued share capital.

It said it was not a party to the placing or retail offer and would not receive any of the proceeds.

Following completion, the foundation would retain 79.4 million shares, equivalent to about 41% of the company's outstanding share capital.

Those remaining shares would be subject to a 365-day lock-up, subject to customary exceptions.

Raspberry Pi also said Arm Technology Investments 2, an existing strategic shareholder, invested about £50m in the placing.

Settlement and closing of both the placing and retail offer were expected on a T+2 basis on 27 April.

Jefferies International and Peel Hunt acted as joint global coordinators and joint bookrunners on the transaction.

At 1137 BST, shares in Raspberry Pi Holdings were down 0.17% at 601p.

Reporting by Josh White for Sharecast.com.

See latest RNS on Investegate

Share this article

Related Sharecast Articles

Berenberg raises target price on Persimmon, keeps 'hold' rating
(Sharecast News) - Analysts at Berenberg raised their target price on housebuilder Persimmon from 1,150p to 1,240p on Friday after lifting their 2026-27 earnings per share estimates by an average of 2% following the group's third-quarter trading update.
Wise H1 profits climb as customer base tops 16m
(Sharecast News) - Global fintech group Wise reported a jump in first-half revenue and profits on Friday, putting the recently dual-listed firm on track to hit the upper end of its full-year growth targets.
GSK wins positive CHMP opinion for Bexsero meningitis B booster
(Sharecast News) - Pharmaceutical giant GSK said on Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use had issued a positive opinion recommending a label update for its Bexsero meningitis B vaccine.
Major Microsoft outage hits hospitals, businesses and financial markets worldwide
(Sharecast News) - A global Microsoft outage has disrupted businesses, government agencies and other organisations worldwide, leaving users without a slew of vital services in what is one of the group's most prolonged service disruptions in history.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.